CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab
Cited by 3
Related Papers
No related papers found
Powered by citation graph analysis
No related papers found
Powered by citation graph analysis